Stem cell therapy and gene transfer for regeneration

Gene Therapy

Volumn 7, Issue 6, 2000, Pages 451-457

  Asahara, T ^a   Kalka, C ^a   Isner, J M ^a,b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ST ELIZABETH'S MEDICAL CENTER   (United States)

Author keywords

Differentiation; Gene therapy; Progenitor cell; Regeneration; Stem cell

Indexed keywords

DNA;

CLONING VECTOR; EMBRYO CELL; ENDOTHELIUM CELL; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; HEMATOPOIETIC STEM CELL; MESENCHYME CELL; NERVE CELL; PRIORITY JOURNAL; REVIEW; STEM CELL; TISSUE REGENERATION;

EID: 0034061559     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3301142     Document Type: Review

References (62)

1. Evans MJ, Kaufman MH. Establishment in culture of pluripotent cells from mouse embryos. Nature 1981; 292: 154-156.
2. Martin GR. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma cells. Proc Natl Acad Sci USA 1981; 78: 7634-7638.
3. Smithies O et al. Insertion of DNA sequences into the human chromosomal beta-globin locus by homologous recombination. Nature 1985; 317: 230-234.
4. Cawpecchi MR. Altering the genome by homologous recombination. Science 1989; 244: 1288-1292.
5. Kennedy M et al. A common precursor for primitive erythropoiesis and definitive haematopoiesis. Nature 1997; 386: 488-493.
6. Hole N, Graham GJ, Menzel U, Ansell JD. A limited temporal window for the derivation of multilineage repopulating hematopoietic progenitors during embryonal stem cell differentiation in vitro. Blood 1996; 88: 1266-1276.
7. Klug MG, Soonpaa MH, Koh GY, Field LJ. Genetically selected cardiomyocytes from differentiating embronic stem cells from stable intracardiac grafts. J Clin Invest 1996; 98: 216-224.
8. Deacon T et al. Blastula-stage stem cells can differentiate into dopaminergic and serotonergic neurons after transplantation. Exp Neurol 1998; 149: 28-41.
9. Brustle O et al. In vitro-generated neural precursors participate in mammalian brain development. Proc Natl Acad Sci USA 1997; 94: 14809-14814.
10. Potocnik AJ, Kohler H, Eichmann K. Hemato-lymphoid in vivo reconstitution potential of subpopulations derived from in vitro differentiated embryonic stem cells. Proc Natl Acad Sci USA 1997; 94: 10295-10300.
11. Thomas JA et al. Embryonic stem cell lines derived from human blastocysts. Science 1998; 282: 1145-1147.
12. Shamblott MJ et al. Derivation of pluripotent stem cells from cultured human primordial germ cells. Proc Natl Acad Sci USA 1998; 95: 13726-13731.
13. Gage FH. Cell therapy. Nature 1998; 392: 18-24.
14. Evans JT, Kelly PF, O'Neill E, Garcia JV. Human cord blood CD34+CD38-cell transduction via lentivirus-based gene transfer vectors. Hum Gene Ther 1999; 10: 1479-1489.
15. Asahara T et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997; 275: 965-967.
16. Kalka C et al. Administration of culture-expanded endothelial progenitor cells (EPC) augments therapeutic neovascularization. Circulation 1998; 98: I-455 (Abstr.).
17. Flax JD et al. Engraftable human neural stem cells respond to developmental cues, replace neurons, and express foreign genes. Nat Biotech 1998; 16: 1033-1039.
18. Lindvall O et al. Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science 1990; 247: 574-577.
19. Schuler JJ et al. Efficacy of prostaglandin E1 in the treatment of lower extremity ischemic ulcers secondary to peripheral vascular occlusive disease. J Vasc Surg 1984; 1: 160-170.
20. Karlsson S. Treatment of genetic defects in hematopoietic cell function by gene transfer. Blood 1991; 78: 2481-2492.
21. Dunbar CE et al. Retroviral transfer of the glucocerebrosidase gene into CD34+ cells from patients with Gaucher disease: in vivo detection of transduced cells without myeloablation. Hum Gene Ther 1998; 9: 2629-2640.
22. Wong-Staal F, Poeschla EM, Looney DJ. A controlled phase 1 clinical trial to evaluate the safety and effects in HIV-1 infected humans of autologous lymphocytes transduced with a ribozyme that cleaves HIV-1 RNA. Hum Gene Ther 1998; 9: 2407-2425.
23. Reisner Y, Segall H. Hematopoietic stem cell transplantation for cancer therapy. Curr Opin Immunol 1995; 7: 687-693.
24. Cowan KH et al. Paclitaxel chemotherapy after autologous stem-cell transplantation and engraftment of hematopoietic cells transduced with a retrovirus containing the multidrug resistance complementary DNA (MDR1) in metastatic breast cancer patients. Clin Cancer Res 1999; 5: 1619-1628.
25. Asahara T et al. Gene therapy of endothelial progenitor cell for vascular development in severe ischemic disease. Circulation 1999; 100: I-480 (Abstr.).
26. Ziegler BL et al. KDR receptor: a key marker defining hematopoietic stem cells. Science 1999; 285: 1553-1558.
27. Hao QL et al. A functional comparison of CD34+ CD38-cells in cord blood and bone marrow. Blood 1995; 86: 3745-3753.
28. Humeau L et al. Successful reconstitution of human hematopoiesis in the SCID-hu mouse by genetically modified, highly enriched progenitors isolated from fetal liver. Blood 1997; 90: 3496-3506.
29. Blaese RM et al. T lymphocyte-directed gene therapy for ADA-SCID: initial trial results after 4 years. Science 1995; 270: 475-480.
30. Folkman J, Shing Y. Angiogenesis. J Biol Chem 1992; 267: 10931-10934.
31. Risau W. Mechanisms of angiogenesis. Nature 1997; 386: 671-674.
32. Ojeifo JO et al. Angiogenesis-directed implantation of genetically modified endothelial cells in mice. Cancer Res 1995; 55: 2240-2244.
33. Asahara T et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 1999; 85: 221-228.
34. Shi Q et al. Evidence for circulating bone marrow-derived endothelial cells. Blood 1998; 92: 362-367.
35. Risau W, Flamme I. Vasculogenesis. Ann Rev Cell Dev Biol 1995; 11: 73-91.
36. Hatzopoulos AK et al. Isolation and characterization of endothelial progenitor cells from mouse embyros. Development 1998; 125: 1457-1468.
37. Takahashi T et al. Ischemia-and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nature Med 1999; 5: 434-438.
38. Asahara T et al. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J 1999; 18: 3964-3972.
39. Groves AK et al. Repair of demyelinated lesions by transplantation of purified 0-2A progenitor cells. Nature 1993; 362: 453-455.
40. Sabate O et al. Transplantation to the rat brain of human neural progenitors that were genetically modified using adenoviruses. Nat Genet 1995; 9: 256-260.
41. Andsberg G et al. Amelioration of ischaemia-induced neuronal death in the rat striatum by NGF-secreting neural stem cells. Eur J Neurosci 1998; 10: 2026-2036.
42. Whittemore SR, Eaton MJ, Onifer SM. Gene therapy and the use of stem cells for central nervous system regeneration. Adv Neurol 1997; 72: 113-119.
43. Clark BR, Keating A. Biology of bone marrow stroma. Ann NY Acad Sci 1995; 770: 70-78.
44. Prockop DJ. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 1997; 276: 71-74.
45. Hurwitz DR et al. Systemic delivery of human growth hormone or human factor IX in dogs by reintroduced genetically modified autologous bone marrow stromal cells. Hum Gene Ther 1997; 8: 137-156.
46. Cherington V et al. Retroviral vector-modified bone marrow stromal cells secrete biologically active factor IX in vitro and transiently deliver therapeutic levels of human factor IX to the plasma of dogs after reinfusion. Hum Gene Ther 1998; 9: 1397-1407.
47. Horwitz EM et al. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nature Med 1999; 5: 309-313.
48. Lou J, Xu F, Merkel K, Manske P. Gene therapy: adenovirus-mediated human bone morphogenetic protein-2 gene transfer induces mesenchymal progenitor cell proliferation and differentiation in vitro and bone formation in vivo. J Orthop Res 1999; 17: 43-50.
49. Anklesaria P et al. Engraftment of a clonal bone marrow stromal cell line in vivo stimulates hematopoietic recovery from total body irradiation. Proc Natl Acad Sci USA 1987; 84:7681-7685.
50. Miller DG, Adam MA, Miller AD. Gene transfer by retroviral vectors occurs only in cells that are actively replicating at the time of infection. Mol Cell Biol 1990; 10: 4239-4242.
51. Havenga M, Hoogerbrugge P, Valerio D, van Es HH. Retroviral stem cell gene therapy. Stem Cells 1997; 15: 162-179.
52. Chu P, Lutzko C, Stewart AK, Dube ID. Retrovirus-mediated gene transfer into human hematopoietic stem cells. J Mol Med 1998; 76: 184-192.
53. Emi N, Friedmann T, Yee JK. Pseudotype formation of murine leukemia virus with the G protein of vesicular stomatitis virus. J Virol 1991; 65: 1201-1207.
54. Kavanaugh MP et al. Cell-surface receptors for gibbon ape leukemia virus and amphotropic muring retrovirus are inducible sodium-dependent phosphate symporters. Proc Natl Acad Sci USA 1994; 91: 7071-7075.
55. Naldini L et al. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 1996; 272: 263-267.
56. Case SS et al. Stable transduction of quiescent CD34(+)CD38(-) human hematopoietic cells by HIV-1-based lentiviral vectors. Proc Natl Acad Sci USA 1999; 96: 2988-2993.
57. Goodman S et al. Recombinant adeno-associated virus-mediated gene transfer into hematopoietic progenitor cells. Blood 1994; 84: 1492-1500.
58. Chatterjee S et al. Transduction of primitive human marrow and cord blood-derived hematopoietic progenitor cells with adeno-associated virus vectors. Blood 1999; 93: 1882-1894.
59. Watanabe T et al. Gene transfer into human bone marrow hematopoietic cells mediated by adenovirus vectors. Blood 1996; 87: 5032-5039.
60. Persons DA et al. Use of the green fluorescent protein as a marker to identify and track genetically modified hematopoietic cells. Nature Med 1998; 4: 1201-1205.
61. Sorrentino BP et al. Selection of drug-resistant bone marrow cells in vivo after retroviral transfer of human MDR1. Science 1992; 257: 99-103.
62. Allay JA et al. In vivo selection of retrovirally transduced hematopoietic stem cells. Nature Med 1998; 4: 1136-1143.